Please try another search
Why small caps are beating the Mag 7 in 2026 Our AI’s read on the market’s structural shift.Plus 2 brand-new stock picks for September revealed at the bottom. Strategy...
When InvestingPro’s Fair Value models flagged Puma Biotechnology, Inc. (NASDAQ:PBYI) as significantly undervalued on November 10, 2025, the healthcare stock was trading at just $4.73. Nine...
Investing.com - Puma Biotech (NASDAQ: PBYI) reported third quarter EPS of $0.210, $0.05 better than the analyst estimate of $0.160. Revenue for the quarter came in at $54.5M versus the consensus...
Instrument Type
Region
Sector
Industry
Date
Category
Provider